Results 161 to 170 of about 286,873 (209)

Reverse engineering the Ozurdex dexamethasone intravitreal implant

International Journal of Pharmaceutics, 2023
Ozurdex is a biodegradable implant formulated for sustained-release delivery of the corticosteroid dexamethasone to the posterior segment of the eye. The small, rod-shaped implant is administered directly to the vitreous using a dedicated applicator, and releases drug for up to 6 months after administration.
Mark A, Costello, Joseph, Liu, Yan, Wang, Bin, Qin, Xiaoming, Xu, Qi, Li, Nathaniel A, Lynd, Feng, Zhang   +7 more
openaire   +2 more sources

Dislocation of Dexamethasone Intravitreous Implant

Archives of Ophthalmology, 2012
tiviral drugs. Eur J Ophthalmol. 2001;11(2):200-202. 22. Yang CM, Wang WW, Lin CP. Progressive outer retinal necrosis syndrome as an early manifestation of human immunodeficiency virus infection. J Formos Med Assoc. 1999;98(2):141-144. 23. Perez-Blazquez E, Traspas R, Mendez Marin I, Montero M.
Voykov, Bogomil Nikolov, Bartz-Schmidt, Karl U.   +1 more
openaire   +3 more sources

Intravitreal Dexamethasone Implant for Macular Edema following Uncomplicated Phacoemulsification

European Journal of Ophthalmology, 2014
Purpose: To retrospectively study the efficacy of a single 0.7-mg dexamethasone intravitreal implant in eyes with refractory macular edema secondary to uncomplicated phacoemulsification and intraocular lens implant.
Giovanni Alessio, Francesco Boscia, Claudio Furino   +2 more
exaly   +3 more sources

Dexamethasone intravitreal implant in serpiginous choroiditis

British Journal of Ophthalmology, 2016
To assess the efficacy and safety of dexamethasone (DEX) intravitreal implant in patients with active serpiginous choroiditis (SC) already receiving maximal tolerated systemic immunosuppressive therapy.In this retrospective longitudinal study we evaluated patients receiving 0.7 mg DEX intravitreal implant for active SC despite maximal systemic ...
Miserocchi, Elisabetta, Berchicci, Luigi, Iuliano, Lorenzo, Modorati, Giulio, Bandello, Francesco   +4 more
openaire   +2 more sources

Spontaneous extrusion of a dexamethasone intravitreal implant (Ozurdex)

BMJ Case Reports, 2020
A 59-year-old man with diabetic macular oedema was treated with a dexamethasone intravitreal implant (Ozurdex) to his right eye. Immediately after injection, the implant was noted to have extruded into the perilimbal subconjunctival space. The remnants of the implant were expeditiously removed the following day to avoid corneal decompensation and ...
Jessica Ong, Nishant Hemanth Davidoss, Anant Bhosale, Chandrakumar Balaratnasingam   +3 more
openaire   +2 more sources

Safety of 6000 intravitreal dexamethasone implants

British Journal of Ophthalmology, 2019
PurposeTo evaluate the real-life safety profile of intravitreal dexamethasone implant injection for various retinal conditions.MethodsRetrospective multicenter analysis of intravitreal dexamethasone implant injections (700 µg) due to various retinal conditions including central retinal venous occlusion (1861 injections), diabetic macular oedema (3104 ...
Masarwa, Dua, Novais, Eduardo, Giancipoli, Ermete, Cagini, Carlo, Bandello, Francesco, Dolz Marco, Rosa, Kumar, S., Sarvaiya, Chintan, Veritti, Daniele, Sarvaiya, Chintan, Veritti, Daniele, Zur, Dinah, Masarwa, Dua, Zur, Dinah, Patyal, S., Kumar, S., Masarwa, Dua, Zur, Dinah, Veritti, Daniele, Sarvaiya, Chintan, Bernal-Morales, Carolina, Cebeci, Zafer, Chaikitmongkol, Voraporn, Sarao, Valentina, Sharma, V., Singh, Sumit Randhir, Cohen, Shai, Fraser-Bell, Samantha, Patyal, S., Kumar, S., Dolz Marco, Rosa, Gallego-Pinazo, Roberto, Shenoy, Prateek, Gabrielle, Pierre-Henry, D'Anna-Mardero, Oriana, Rajesh, Bindu, Rassu, Nicolo, Asencio-Duran, Monica, Maia, Mauricio, Cavalleri, Michele, Rasheed, Mohammed Abdul, Nagpal, Manish, Casella, Marcelo, Lupidi, Marco, Avila, Marcos, Berrocal, Maria, Cavalleri, Michele, Maia, Mauricio, Iglicki, Matias, Berrocal, Maria, Avila, Marcos, Iglicki, Matias, Lupidi, Marco, Casella, Marcelo, Rasheed, Mohammed Abdul, Asencio-Duran, Monica, Rassu, Nicolo, Ayhan, Ziya, Cebeci, Zafer, Al-khersan, Hasenin, Wong, J. S., Chaikitmongkol, Voraporn, Nagpal, Manish, Okada, Mali, Wu, Lihteh, Raji, K., Sarao, Valentina, Sharma, V., Singh, Sumit Randhir, Cohen, Shai, Fraser-Bell, Samantha, Patyal, S., Novais, Eduardo, Giancipoli, Ermete, Raji, K., Wu, Lihteh, Okada, Mali, Bandello, Francesco, D'Anna-Mardero, Oriana, Gabrielle, Pierre-Henry, Shenoy, Prateek, Gallego-Pinazo, Roberto, Wong, J. S., Al-Khersan, Hasenin, Sharma, Ashish, Sala-Puigdollers, Anna, Maiti, Aniruddha, Maia, Andre, AYHAN, ZİYA, SAATCİ, ALİ OSMAN, Dolz Marco, Rosa, Gallego-Pinazo, Roberto, Shenoy, Prateek, Gabrielle, Pierre-Henry, D'Anna-Mardero, Oriana, Marashi, Ameen, Rassu, Nicolo, Asencio-Duran, Monica, Rasheed, Mohammed Abdul, Cavalleri, Michele, Maia, Mauricio, Iglicki, Matias, Berrocal, Maria, Avila, Marcos, Lupidi, Marco, Casella, Marcelo, Nagpal, Manish, Bernal-Morales, Carolina, Sen, Alok C., Banker, Alay, Mansour, Ahmad, Goud, Abhilash, Singh, A., Gupta, A., Chhablani, Jay, Kodjikian, Laurent, Arevalo, J. Fernando, Lanzetta, Paolo, Okada, Mali, Farah, Michel Eid, Querques, Giuseppe, Udaondo Mirete, Patricia, Mishra, Sanjay Kumar, Wu, Lihteh, Sarao, Valentina, Rodriguez-Valdes, Patricio J., Sahoo, Niroj Kumar, Busch, Catharina, Fung, Adrian T., Zarranz-Ventura, Javier, Raji, K., Wong, J. S., Al-khersan, Hasenin, Bandello, Francesco, Giancipoli, Ermete, Novais, Eduardo, Bernal-Morales, Carolina, Ayhan, Ziya, Cebeci, Zafer, Chaikitmongkol, Voraporn, Sarao, Valentina, Sharma, V., Singh, Sumit Randhir, Cohen, Shai, Fraser-Bell, Samantha   +144 more
openaire   +7 more sources

INTRAVITREAL DEXAMETHASONE IMPLANTATION FOR BIRDSHOT CHORIORETINOPATHY

RETINAL Cases & Brief Reports, 2017
Purpose: Birdshot chorioretinopathy is a rare form of posterior uveitis. This article reports a case series of patients with HLA-A29+ birdshot chorioretinopathy managed with intravitreal dexamethasone implants.
James, Walsh, Ashvini K, Reddy
openaire   +2 more sources

Dexamethasone Intravitreal Implant (Ozurdex)

Canadian Journal of Health Technologies, 2023
CADTH recommends that Ozurdex not be reimbursed by public drug plans for the treatment of adult patients with diabetic macular edema (DME) who are pseudophakic and have had an inadequate response to prior anti–vascular endothelial growth factor (VEGF) therapy. Evidence from 1 clinical trial and 2 observational studies was insufficient to demonstrate
openaire   +1 more source

PERSISTENT REMNANTS OF DEXAMETHASONE INTRAVITREAL IMPLANT (OZURDEX)

Retina, 2020
Purpose: To describe persistent remnants of dexamethasone intravitreal implant (DEX implant) and evaluate the risk factors for remnant persistence in patients who received a DEX implant. Methods: This retrospective observational study involved a retrospective chart review of 133 ...
Jee Taek, Kim, Seok Hyun, Lee, Sang Uk, Choi   +2 more
openaire   +2 more sources